| Fresenius Kabi (Schweiz) AG - Irinotecan Fresenius 300 mg/15 ml, Infusionskonzentrat |
| 61246 | | 03 | | Irinotecan Fresenius 300 mg/15 ml | | Infusionskonzentrat | | L01CE02 | | Irinotecan | | 28.01.2011 | | |
|
| Composition |
| irinotecani hydrochloridum trihydricum 300 mg, sorbitolum, acidum lacticum, aqua ad iniectabile q.s. ad solutionem pro 15 ml. |
| Packungsbestandteile |
| Concentrate for infusion | | | | | | | | Active Agent | Dose |
|---|
| Irinotecan Hydrochloride Trihydrate | 300mg / 15ml |
| | BAG: Active Agent | Dose |
|---|
| Irinotecan Hydrochloride Trihydrate | 300 mg |
| | | | Inactive agents |
|---|
| Lactic Acid | | Sorbitol |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 019 | | 245.64 | 283.55 | A | SL | Yes |
|
